Stroke Treatment With Acute Reperfusion and Simvastatin

Completed

Phase 4 Results N/A

Summary of Purpose

The purpose of this study is to determine whether simvastatin treatment started within the first 12 hours from stroke onset improves neurological and functional outcomes, evaluated at seventh day/discharge or at the third month. Also, to demonstrate that simvastatin is safe and not associated with higher rates of hemorrhagic transformation in patients who receive thrombolysis.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 18 June 2015.

1 Apr 2009 18 Feb 2010 1 Jun 2014 1 Jun 2014 1 Jun 2014 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

  • Joan Montaner, MD, PhD